Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
CaAKG Reverses Alzheimer's Synaptic Deficits in Mice via Autophagy BoostLongevity & Aging

CaAKG Reverses Alzheimer's Synaptic Deficits in Mice via Autophagy Boost

Researchers at the National University of Singapore tested calcium alpha-ketoglutarate (CaAKG) — a TCA-cycle metabolite already linked to lifespan extension — in APP/PS1 Alzheimer's mice. CaAKG restored long-term potentiation (LTP) at hippocampal CA1 synapses, with stronger effects in females than males. The rescue worked through an NMDA-receptor-independent pathway involving L-type calcium channels and calcium-permeable AMPA receptors. CaAKG also elevated LC3-II, a marker of autophagy, and facilitated synaptic tagging and capture — a cellular model of associative memory. Rapamycin, an mTOR inhibitor, mirrored these effects in AD mice but paradoxically blocked LTP in wild-type animals, suggesting the autophagy pathway is particularly important when synaptic function is already compromised.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.